Literature DB >> 19693478

[Functional magnetic resonance tomography in patients with schizophrenia: neural correlates of symptoms, cognition and emotion].

T Kircher1, D Leube, U Habel.   

Abstract

In patients with schizophrenia, numerous mental processes are impaired, which can be related to brain systems using functional imaging methods (e.g. functional magnetic resonance imaging; fMRI). In this review the methodological and conceptual background of fMRI will first be discussed. Secondly, the cerebral networks involved in important symptoms of schizophrenia such as hallucinations, delusions and formal thought disorders will be outlined. Furthermore, the pathways of the central nervous system involved in cognitive dysfunction in patients with schizophrenia will be described also in the dependence on genotype and medicinal status. Functional imaging methods provide psychiatry and psychotherapy with the unique opportunity to correlate mental processes and dysfunctions with neural networks.

Entities:  

Mesh:

Year:  2009        PMID: 19693478     DOI: 10.1007/s00115-009-2814-1

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  39 in total

1.  The neural consequences of conflict between intention and the senses.

Authors:  G R Fink; J C Marshall; P W Halligan; C D Frith; J Driver; R S Frackowiak; R J Dolan
Journal:  Brain       Date:  1999-03       Impact factor: 13.501

2.  Functional dissociation between medial and lateral prefrontal cortical spatiotemporal activation in negative and positive emotions: a combined fMRI/MEG study.

Authors:  G Northoff; A Richter; M Gessner; F Schlagenhauf; J Fell; F Baumgart; T Kaulisch; R Kötter; K E Stephan; A Leschinger; T Hagner; B Bargel; T Witzel; H Hinrichs; B Bogerts; H Scheich; H J Heinze
Journal:  Cereb Cortex       Date:  2000-01       Impact factor: 5.357

3.  Disorders of agency in schizophrenia correlate with an inability to compensate for the sensory consequences of actions.

Authors:  Axel Lindner; Peter Thier; Tilo T J Kircher; Thomas Haarmeier; Dirk T Leube
Journal:  Curr Biol       Date:  2005-06-21       Impact factor: 10.834

4.  Pathophysiology of 'positive' thought disorder in schizophrenia.

Authors:  P K McGuire; D J Quested; S A Spence; R M Murray; C D Frith; P F Liddle
Journal:  Br J Psychiatry       Date:  1998-09       Impact factor: 9.319

5.  Abnormal object recall and anterior cingulate overactivation correlate with formal thought disorder in schizophrenia.

Authors:  Michal Assaf; Paul R Rivkin; Cheedem H Kuzu; Vince D Calhoun; Michael A Kraut; Karyn M Groth; Michael A Yassa; John Hart; Godfrey D Pearlson
Journal:  Biol Psychiatry       Date:  2005-09-30       Impact factor: 13.382

6.  Neural correlates of formal thought disorder in schizophrenia: preliminary findings from a functional magnetic resonance imaging study.

Authors:  T T Kircher; P F Liddle; M J Brammer; S C Williams; R M Murray; P K McGuire
Journal:  Arch Gen Psychiatry       Date:  2001-08

7.  A PET study of voluntary movement in schizophrenic patients experiencing passivity phenomena (delusions of alien control).

Authors:  S A Spence; D J Brooks; S R Hirsch; P F Liddle; J Meehan; P M Grasby
Journal:  Brain       Date:  1997-11       Impact factor: 13.501

Review 8.  The role of negative symptoms and cognitive dysfunction in schizophrenia outcome.

Authors:  C A Tamminga; R W Buchanan; J M Gold
Journal:  Int Clin Psychopharmacol       Date:  1998-03       Impact factor: 1.659

9.  Impairment in the specificity of emotion processing in schizophrenia.

Authors:  Frank Schneider; Ruben C Gur; Kathrin Koch; Volker Backes; Katrin Amunts; N Jon Shah; Warren Bilker; Raquel E Gur; Ute Habel
Journal:  Am J Psychiatry       Date:  2006-03       Impact factor: 18.112

10.  Is emotion processing a predictor of functional outcome in schizophrenia?

Authors:  Kimmy S Kee; Michael F Green; Jim Mintz; John S Brekke
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

View more
  1 in total

Review 1.  [Alcohol induced cognitive deficits].

Authors:  Elisabeth Weiss; Evelin M Singewald; Beatrix Ruepp; Josef Marksteiner
Journal:  Wien Med Wochenschr       Date:  2013-07-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.